Skip to content

Protected: Studies

A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients with Knee Osteoarthritis

Calendar Name AbbVie M13-741
Description This Phase 2 study will assess the safety, efficacy, and pharmacodynamic effects of ABT-981 on osteoarthritis (OA) knee. Patients will be randomized to one of the four treatment groups to receive eith
PI Thomas Schnitzer
People Katie Rankin | Alexandra Coello | Tiana Zdravkovich
Business Administrator -
Resources 3T Trio
IRB STU00089961
Start Date 2014-05-05
End Date
Chart String 640-5250100-60036444
Affiliates No